What is the risk of placenta accreta during future pregnancies in a patient who underwent myomectomy with entry into the endometrial cavity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Your patient faces an increased risk of placenta accreta spectrum in future pregnancies due to the endometrial cavity entry during myomectomy, and this risk will escalate dramatically if placenta previa develops overlying the myomectomy scar. 1

Understanding Why This Creates Risk

  • The American College of Obstetricians and Gynecologists identifies prior uterine surgeries—including myomectomy—as established risk factors for placenta accreta spectrum, alongside cesarean delivery, curettage, and Asherman syndrome 2, 1

  • Entry into the endometrial cavity is particularly concerning because it creates a full-thickness defect in the endometrial-myometrial interface, similar to cesarean delivery, rather than a subserosal defect that would spare the decidual layer 1

  • This disruption damages the endometrial-myometrial interface where normal decidualization should occur, allowing abnormally deep placental anchoring and trophoblast infiltration in areas of uterine scarring 2, 1

Quantifying the Risk

  • While the absolute magnitude of increased risk after myomectomy is not as precisely quantified as it is for cesarean delivery (where risk ranges from 0.3% after one cesarean to 6.74% after five cesareans), the mechanism of injury is comparable when the endometrial cavity is entered 1

  • The critical scenario to monitor for is placenta previa overlying the myomectomy scar—this combination creates the same "perfect storm" seen with cesarean scars, where abnormal placental location overlies damaged uterine tissue 1, 3

  • If placenta previa develops over the myomectomy scar, expect risk levels similar to the cesarean-previa combination: 11% with one prior surgery, escalating to 40-67% with multiple surgeries 2, 1

Clinical Evidence Supporting This Risk

  • Case reports document placenta accreta occurring at myomectomy sites, particularly when the placenta overlies uterine abnormalities or surgical scars 4

  • A retrospective cohort study of 367 women with prior myomectomy undergoing cesarean delivery found significantly increased rates of cesarean hysterectomy (1.4% vs 0.2%, adjusted OR 3.43) and transfusion requirements compared to controls 5

  • Hysteroscopic myomectomy cases have resulted in placenta increta, demonstrating that even minimally invasive approaches that enter the endometrial cavity create accreta risk 6

Surveillance Strategy for Future Pregnancies

  • Obtain early ultrasound at 18-20 weeks to identify placental location relative to the myomectomy scar 1, 7

  • If the placenta is not overlying the scar, the risk remains elevated but substantially lower than the previa-scar combination 1

  • Gray-scale ultrasound should be your first-line imaging modality, specifically looking for: loss of the normal hypoechoic retroplacental zone, placental lacunae, thinning of the uterine serosa-bladder interface (<1mm), and abnormal placental vascularity 1, 7

  • If ultrasound findings are equivocal and clinical suspicion remains high, MRI can provide additional diagnostic information 8, 6

Critical Caveat About Negative Imaging

  • The absence of ultrasound findings does not rule out placenta accreta—clinical risk factors (like your patient's endometrial cavity entry during myomectomy) remain equally important predictors 7

  • Interobserver variability in ultrasound interpretation is substantial, so maintain high clinical suspicion regardless of initial imaging reports 7

Delivery Planning If Accreta Is Suspected

  • Delivery must occur at a level III or IV maternal care facility with multidisciplinary capabilities, including maternal-fetal medicine, pelvic surgeons, urologists, interventional radiologists, obstetric anesthesiologists, and blood bank with massive transfusion protocols 2, 7, 3

  • Planned cesarean delivery should occur at 34 0/7 to 35 6/7 weeks gestation to balance neonatal outcomes against maternal hemorrhage risk, as approximately 50% of women with accreta who wait beyond 36 weeks require emergent delivery for hemorrhage 7, 3

  • The standard surgical approach is cesarean hysterectomy with the placenta left in situ—attempting placental removal results in catastrophic hemorrhage and should be avoided 7, 3, 8

References

Guideline

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Placenta Accreta Spectrum Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Placenta accreta: an association with fibroids and Asherman syndrome.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Research

Perinatal outcomes of women undergoing cesarean delivery after prior myomectomy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2020

Research

Placenta increta after hysteroscopic myomectomy.

Obstetrics and gynecology, 2013

Guideline

Diagnosing and Managing Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Committee opinion no. 529: placenta accreta.

Obstetrics and gynecology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.